Aptus Pharma Ltd.

Insufficient data

FAQs on Aptus Pharma Ltd. Shareprice

Has the share price of Aptus Pharma grown faster than its competition?

There is not enough historical data for the companies share price.

Is Aptus Pharma stock expensive?

There is insufficient historical data to gauge this.
Latest PE of Aptus Pharma is 0

View FAQ's On Business

Reverse DCF

Earnings

Discount Rate (%)

Terminal Multiple

5 YEAR

10 YEAR

20 YEAR

Implied Growth Rate over a 5 year period*

Implied Growth Rate over a 10 year period*

Implied Growth Rate over a 20 year period*

*Implied Growth calculated using Newton-Raphson method.

Learn how to use Reverse DCF

FAQs on Aptus Pharma Ltd. Financials

How strong is Aptus Pharma balance sheet?

Aptus Pharma balance sheet is weak and might have solvency issues

Is the debt of Aptus Pharma increasing or decreasing?

The net debt of Aptus Pharma is decreasing.
Latest net debt of Aptus Pharma is ₹0.69 Crs as of Mar-25.
This is less than Mar-24 when it was ₹4.25 Crs.

Is the profitablity of Aptus Pharma improving?

Yes, profit is increasing.
The profit of Aptus Pharma is ₹3.1 Crs for Mar 2025, ₹0.8 Crs for Mar 2024 and ₹0.19 Crs for Mar 2023

Does Aptus Pharma pay decent dividends?

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aptus Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Aptus Pharma allocated its funds?

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory

View FAQ's On Shareholding